2-Phenylbenzimidazole-5-sulfonic acid

• CAS: 27503-81-7
• Catalog Number: ACM27503817
• Category: Main Products
• Molecular Weight: 274.3
• Molecular Formula: C₁₃H₁₀N₂O₃S
• Synonyms: PARSOL HS;NEO HELIOPAN HYDRO;PHENYLBENZIMIDAZOLE SULFONIC ACID;LABOTEST-BB LT00454150;EUSOLEX 232;2-PHENYL-1H-BENZOIMIDAZOLE-5-SULFONIC ACID;2-PHENYL-1H-BENZO[D]IMIDAZOLE-5-SULFONIC ACID;2-PHENYL-5-BENZIMIDAZOLESULFONIC ACID
• IUPAC Name: 2-phenyl-3H-benzimidazole-5-sulfonicacid
• Canonical SMILES: C1=CC=C(C=C1)C2=NC3=C(N2)C=C(C=C3)S(=O)(=O)O
• InChI Key: UVCJGUGAGLDPAA-UHFFFAOYSA-N
• Melting Point: 300ºC
• Flash Point: >100ºC
• Density: 1.497g/cm³
• Appearance: white fine crystalline powder
• EC Number: 248-502-0
• Exact Mass: 274.04100
• Hazard Statements: Xi:Irritant
• Safety Description: S26-S36
• Stability: Stable under normal temperatures and pressures. May decompose when exposed to light.

Custom Q&A

What is the molecular formula of Ensulizole?

The molecular formula of Ensulizole is C13H10N2O3S.

What is the molecular weight of Ensulizole?

The molecular weight of Ensulizole is 274.30 g/mol.

When was Ensulizole created?

Ensulizole was created on July 12, 2005.

What is another name for Ensulizole?

Another name for Ensulizole is 2-Phenylbenzimidazole-5-sulfonic acid.

What is the IUPAC name of Ensulizole?

The IUPAC name of Ensulizole is 2-phenyl-3H-benzimidazole-5-sulfonic acid.

What is the InChIKey of Ensulizole?

The InChIKey of Ensulizole is UVCJGUGAGLDPAA-UHFFFAOYSA-N.

What is the Canonical SMILES of Ensulizole?

The Canonical SMILES of Ensulizole is C1=CC=C(C=C1)C2=NC3=C(N2)C=C(C=C3)S(=O)(=O)O.

What is the CAS number of Ensulizole?

The CAS number of Ensulizole is 27503-81-7.

What is the XLogP3 value of Ensulizole?

The XLogP3 value of Ensulizole is 2.

What is the maximum approved concentration of Ensulizole according to the FDA?

According to the FDA, the maximal approved concentration of Ensulizole is 148 mM.

Synthetic Use

Upstream Synthesis Route 1

• 93-58-3

• 27503-81-7

Reference: [1]Current Patent Assignee: MERCK KGAA - US5473079, 1995, A

Downstream Synthesis Route 1

• 27503-81-7

• 27503-82-8

Reference: [1]Current Patent Assignee: ALUMEND LLC - US2005/113288, 2005, A1
Location in patent: Page/Page column 15; Sheet 5
[2]Current Patent Assignee: Novartis (w/o Sandoz); NOVARTIS AG - US2012/28969, 2012, A1
Location in patent: Page/Page column 52

* For details of the synthesis route, please refer to the original source to ensure accuracy.